1.
Int J Dermatol
; 60(3): 384-386, 2021 Mar.
Article
in English
| MEDLINE | ID: covidwho-991417
Subject(s)
Ageusia/drug therapy , Anosmia/drug therapy , COVID-19/complications , Doxycycline/therapeutic use , Erythema/drug therapy , Skin Diseases, Genetic/drug therapy , Adult , Ageusia/diagnosis , Ageusia/immunology , Anosmia/diagnosis , Anosmia/immunology , Biopsy , COVID-19/diagnosis , COVID-19/immunology , COVID-19/virology , COVID-19 Serological Testing , Drug Repositioning , Erythema/diagnosis , Erythema/immunology , Erythema/pathology , Female , Humans , SARS-CoV-2/immunology , SARS-CoV-2/isolation & purification , Skin/immunology , Skin/pathology , Skin Diseases, Genetic/diagnosis , Skin Diseases, Genetic/immunology , Skin Diseases, Genetic/pathology , Treatment Outcome
2.
J Neurovirol
; 26(5): 785-789, 2020 10.
Article
in English
| MEDLINE | ID: covidwho-647060
ABSTRACT
Over the course of the pandemic due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), multiple new clinical manifestations, as the consequence of the tropism of the virus, have been recognized. That includes now the neurological manifestations and conditions, such as headache, encephalitis, as well as olfactory and taste disorders. We present a series of ten cases of RT-PCR-confirmed SARS-CoV-2-infected patients diagnosed with viral-associated olfactory and taste loss from four different countries.